Abstract
5-Lipoxygenase (5-LOX) is important enzyme in the biosynthesis of leukotrienes, and is a potential target in the treatment of asthma and allergy. We designed and synthesized a series of benzoxazoles and benzothiazoles as 5-LOX inhibitors. Fourteen compounds prepared showed the inhibition of LTC4 formation with IC50 value of 0.12-23.88 μM. Also two compounds 2d and 2g showed improved airway hypersensitiveness.
Original language | English |
---|---|
Pages (from-to) | 7580-7585 |
Number of pages | 6 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 18 |
Issue number | 21 |
DOIs | |
Publication status | Published - 2010 Nov 1 |
Bibliographical note
Funding Information:This work was supported by a Grant (title: Development of new technology for next generation, NBM1200513 ) from Ministry of Knowledge Economy in Korea .
All Science Journal Classification (ASJC) codes
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry